Ritz peanut butter cracker sandwiches are being recalled as a result of doable presence of undeclared peanuts, a serious allergen.
Mondelēz World LLC introduced the voluntary recall on July 8, and the U.S. Meals and Drug Administration (FDA) issued a Class II threat warning for the sandwiches on July 22. Class II remembers imply consuming the affected product poses a reasonable threat to public well being, based on the FDA.
No experiences of damage or sickness related to consuming the affected cracker sandwiches have been reported to this point.
Allergic reactions to peanuts vary in severity from gentle signs, similar to hives and lip swelling, to life-threatening anaphylaxis. Peanut allergy is the most typical reason for life-threatening anaphylaxis as a consequence of meals, based on the Mayo Clinic.
The producer initiated the recall after it found that movie packaging rolls used to wrap particular person peanut butter merchandise may “contain defects due to a supplier error.”
The affected sandwiches are offered at retail shops nationwide and embody:
Ritz Peanut Butter Cracker Sandwiches eight-pack, 37,985 circumstances—with the UPC 0 44000 88210 5 and best-by dates of Nov. 1-9, 2025
Ritz Peanut Butter Cracker Sandwiches 20-pack, 24,446 circumstances—with the UPC 0 44000 07584 2 and best-by dates of Nov. 1-9, 2025, or Jan. 2-22, 2026
Ritz Peanut Butter Cracker Sandwiches, 224 circumstances—with the UPC 0 44000 07819 5 and best-by dates of Nov. 1-9, 2025, or Jan. 2-22, 2026
Ritz Stuffed Cracker Sandwich 20-count selection pack, 13,872 circumstances — with the UPC 0 44000 08095 2 and best-by dates of Nov. 2-9, 2025
Shoppers who bought the affected merchandise and have a peanut allergy mustn’t eat them and might contact the corporate at 844-366-1171 with any questions.
Extra info:
Be taught extra about peanut allergy on the American Academy of Allergy, Bronchial asthma & Immunology
Quotation:
Ritz replace: FDA points threat warning as a consequence of undeclared peanuts in some cracker sandwiches (2025, July 25)
retrieved 25 July 2025
from https://medicalxpress.com/information/2025-07-ritz-fda-issues-due-undeclared.html
This doc is topic to copyright. Other than any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.
